Related references
Note: Only part of the references are listed.Baicalin attenuates myocardial ischemia-reperfusion injury through Akt/NF-κB pathway
Yun Luan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
Ying Jiang et al.
NATURE (2019)
Proteomics in Drug Development: The Dawn of a New Era?
Maria Frantzi et al.
PROTEOMICS CLINICAL APPLICATIONS (2019)
Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm
Paul R. Albert et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2019)
Neural basis of major depressive disorder: Beyond monoamine hypothesis
Shuken Boku et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2018)
Baicalin Modulates APPL2/Glucocorticoid Receptor Signaling Cascade, Promotes Neurogenesis, and Attenuates Emotional and Olfactory Dysfunctions in Chronic Corticosterone-Induced Depression
Chong Gao et al.
MOLECULAR NEUROBIOLOGY (2018)
Neurobiology of Depression and Mechanism of Action of Depression Treatments
Pierre Blier
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Baicalin promotes hippocampal neurogenesis via SGK1-and FKBP5-mediated glucocorticoid receptor phosphorylation in a neuroendocrine mouse model of anxiety/depression
Kuo Zhang et al.
SCIENTIFIC REPORTS (2016)
Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis
Li Cai et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Mechanisms of stress in the brain
Bruce S. McEwen et al.
NATURE NEUROSCIENCE (2015)
Glucocorticoid actions on synapses, circuits, and behavior: Implications for the energetics of stress
Brent Myers et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2014)
Glucocorticoid Receptor and FKBP5 Expression Is Altered Following Exposure to Chronic Stress: Modulation by Antidepressant Treatment
Gianluigi Guidotti et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis
Christoph Anacker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior
Ting-Ching Wu et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Baicalin attenuates proinflammatory cytokine production in oxygen-glucose deprived challenged rat microglial cells by inhibiting TLR4 signaling pathway
Jincai Hou et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Neurogenesis-Independent Antidepressant-Like Effects on Behavior and Stress Axis Response of a Dual Orexin Receptor Antagonist in a Rodent Model of Depression
Mathieu Nollet et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Ronald S. Duman et al.
SCIENCE (2012)
Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor
C. Anacker et al.
MOLECULAR PSYCHIATRY (2011)
The glucocorticoid receptor: Pivot of depression and of antidepressant treatment?
Christoph Anacker et al.
PSYCHONEUROENDOCRINOLOGY (2011)
New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
Min Li-Weber
CANCER TREATMENT REVIEWS (2009)
Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/Depression
Denis J. David et al.
NEURON (2009)
Glucocorticoid receptor interaction with TrkB promotes BDNF-triggered PLC-γ signaling for glutamate release via a glutamate transporter
Tadahiro Numakawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The HPA axis in major depression: classical theories and new developments
Carmine M. Pariante et al.
TRENDS IN NEUROSCIENCES (2008)
Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress
C Tsigos et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2002)
Share Paper
